FdaApplication
NDA 020591
Identifiers
- fda_app_no: NDA020591
Properties
| Property | Value |
|---|---|
| applicant_name | ABBVIE INC |
| application_type | NDA |
| approval_date | 1996-10-22 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TARKA | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | 4MG;240MG | TABLET, EXTENDED RELEASE;ORAL |
| TARKA | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE;ORAL |
| TARKA | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | 2MG;240MG | TABLET, EXTENDED RELEASE;ORAL |
| TARKA | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | 2MG;180MG | TABLET, EXTENDED RELEASE;ORAL |
4 products